Rivaroxaban treatment of cancer‐associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience

BACKGROUND: Low‐molecular‐weight heparin has been the preferred treatment of cancer‐associated thrombosis (CAT); however, emerging data support the use of direct oral anticoagulants (DOACs). OBJECTIVES: The Memorial Sloan Kettering Cancer Center Clinical Pathway has served as the institutional guide...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Res Pract Thromb Haemost
Main Authors: Soff, Gerald A., Mones, Jodi, Wilkins, Cy, Devlin, Sean, Haegler‐Laube, Eva, Wills, Jonathan, Sarasohn, Debra M., Juluru, Krishna, Singer, Michael, Miao, Yimei, Batista, Jeanette, Mantha, Simon
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Original Articles: Thrombosis
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6611365/
https://ncbi.nlm.nih.gov/pubmed/31294321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12215
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki